Mechanism

Cysteinyl leukotriene receptor 1 (CysLT1) / PDE3 / PDE4 / 5-lipoxygenase

Assets acting on this target.

Class
Multi-pathway anti-inflammatory/anti-fibrotic small molecule (leukotriene receptor antagonist + phosphodiesterase inhibitor)
Pathway
Blocks leukotriene D4 signaling and inhibits PDE3/PDE4 (raising intracellular cAMP), with upstream 5-LO suppression, reducing vascular/hepatic inflammation and fibrosis
Research

Explore this mechanism at different depths

Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.

Company

1 of 1 assets

← all assets